Skip to content
Diagnosis

Desert Oasis Healthcare Reports a 46% Increase in Dementia Diagnoses with Neurotrack

The latest chapter in our partnership with Desert Oasis Healthcare, and what a full year of consistent cognitive assessment and coordinated dementia care has delivered.

The latest chapter in our partnership with Desert Oasis Healthcare, and what a full year of consistent cognitive assessment and coordinated dementia care has delivered.

Since Desert Oasis Healthcare (DOHC) standardized its cognitive assessment workflow with Neurotrack in 2024, we have shared its progress at a few points along the way: a 29% increase in the dementia diagnosis rate in the first four months, followed by a 35% net increase in new dementia cases through September 2025.

This week at America's Physician Groups (APG), DOHC's team has presented the full-year picture, and the results show a trend that has continued to build across all of 2025.

A full year of results

Between 2024 and 2025, dementia diagnoses across DOHC's population rose 46%, and diagnosed dementia prevalence climbed from 5.2% to 7.6%. Of the roughly 105,000 adults 65 and older in the Greater Palm Springs area, an estimated 19,000 live with dementia or significant cognitive impairment, yet in 2024 DOHC's diagnosed prevalence sat just below the national rate of 5.3% and well below Riverside County's 8.7%. A year later, DOHC's rate is above the national figure and closer to the county's, which means more patients who were already living with dementia are now diagnosed and can be connected to the care they need.

Diagnoses increased at every level of severity

DOHC's poster also breaks diagnoses out by CMS-HCC V28 severity category:

HCC Category

2024

2025

Change

HCC 127: Mild dementia

1,395

1,953

+40%

HCC 126: Moderate dementia

157

312

+99%

HCC 125: Severe dementia

81

119

+47%

Total

1,633

2,384

+46%

 

Mild dementia accounts for the largest share of diagnosed patients, while moderate dementia diagnoses roughly doubled. Under CMS-HCC V28, which separates dementia into three distinct severity categories, a specific and well-documented diagnosis is what allows a population's true clinical needs to be reflected in care planning and risk adjustment alike.

Detection paired with a path to care

DOHC describes these results as the product of a two-part initiative. The first part replaced traditional cognitive assessment methods with Neurotrack across DOHC's Senior Wellness Clinics, combined with provider education, so primary care providers were working from a standardized and consistent process. The second part focused on what happens after a positive result: DOHC adapted the Alzheimer's and Dementia Care (ADC) model in its Dementia Care Clinic, where a clinical pharmacist serves as the dementia care specialist alongside a neurologist, evaluating daily functioning, reviewing testing and imaging results, optimizing medications, and linking patients and families to community resources.

The workflow connecting the two is clear and repeatable. Neurotrack is administered during the Annual Wellness Visit, and patients with a positive result are referred to the Dementia Care Clinic, where the team gathers additional history on daily functioning from the patient and a family member. Patients showing functional impairment move on to neurology for further evaluation, those diagnosed with dementia return to the clinic for long-term management, and everyone else is referred back to primary care for routine follow-up.

"By integrating Neurotrack's screening into routine visits, we're catching issues earlier, easing the burden on specialists, and giving our patients the clarity and support they need at a critical time." -Brian Hodgkins, PharmD, EVP of Clinical Operations, Desert Oasis Healthcare

What medical groups can take from DOHC's model

Earlier dementia diagnosis in a team-based primary care model can improve patients' access to needed resources and help them navigate the dementia care journey. For other medical groups, the takeaway is that the two halves depend on each other: consistent, clinically validated assessment at the Annual Wellness Visit identifies the patients, and a defined pathway afterward ensures that identification leads to diagnosis and care.

Neurotrack's role sits at the foundation of that pathway, with clinically validated digital assessments embedded into routine wellness visits, results delivered directly to the EHR, and a patient experience available in both English and Spanish. DOHC now assesses approximately 20,000 patients per year this way.

View DOHC's full APG poster

We Handed Primary Care an Impossible Job
Next Post

We Handed Primary Care an Impossible Job

See what earlier detection can do for your patients and your health system

Join the health systems and care organizations already closing the confidence gap in cognitive care. Request a demo today and see Neurotrack in action.

Request a Demo

Have questions? Contact us →